These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 25080020)

  • 1. The problem of embedded decision nodes in cost-effectiveness decision trees.
    Arias M; Díez FJ
    Pharmacoeconomics; 2014 Nov; 32(11):1141-5. PubMed ID: 25080020
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness Analysis with Influence Diagrams.
    Arias M; Díez FJ
    Methods Inf Med; 2015; 54(4):353-8. PubMed ID: 25762363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An introduction to the methods of cost-effectiveness analysis.
    Drug Ther Bull; 2012 Jul; 50(7):81-4. PubMed ID: 22789768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for conducting and reporting cost-effectiveness analysis in nursing.
    Stone PW
    Image J Nurs Sch; 1998; 30(3):229-34. PubMed ID: 9753837
    [No Abstract]   [Full Text] [Related]  

  • 5. It is money that matters: decision analysis and cost-effectiveness analysis.
    Kocher MS; Henley MB
    Clin Orthop Relat Res; 2003 Aug; (413):106-16. PubMed ID: 12897601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoeconomic analyses: whose perspective counts and costs the most?
    Rubenstein EB; Elting LS
    Am J Hosp Pharm; 1994 Jun; 51(12):1564-9. PubMed ID: 8092157
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.
    Shah SV; Gage BF
    Circulation; 2011 Jun; 123(22):2562-70. PubMed ID: 21606397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of decision analysis to evaluate the costs and benefits of filgrastim (G-CSF) therapy.
    Peroutka JA; Mutnick AH
    Formulary; 1995 Jul; 30(7):394-5, 400-4. PubMed ID: 10151731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical use of decision analysis.
    Lawler FH
    Prim Care; 1995 Jun; 22(2):281-93. PubMed ID: 7617787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis in radiology.
    Singer ME; Applegate KE
    Radiology; 2001 Jun; 219(3):611-20. PubMed ID: 11376244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision and cost-effectiveness analysis.
    Marley DS
    J Fam Pract; 1990 Feb; 30(2):233, 236. PubMed ID: 2105374
    [No Abstract]   [Full Text] [Related]  

  • 12. Using decision analysis to assess comparative clinical efficacy of surgical treatment of unstable ankle fractures.
    Michelson JD
    J Orthop Trauma; 2013 Nov; 27(11):642-8. PubMed ID: 23481924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of the diagnostic evaluation of vertigo.
    Stewart MG; Chen AY; Wyatt JR; Favrot S; Beinart S; Coker NJ; Jenkins HA
    Laryngoscope; 1999 Apr; 109(4):600-5. PubMed ID: 10201748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug policy for visceral leishmaniasis: a cost-effectiveness analysis.
    Vanlerberghe V; Diap G; Guerin PJ; Meheus F; Gerstl S; Van der Stuyft P; Boelaert M
    Trop Med Int Health; 2007 Feb; 12(2):274-83. PubMed ID: 17300636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model.
    Hillner BE; Smith TJ
    N Engl J Med; 1991 Jan; 324(3):160-8. PubMed ID: 1898533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of endovascular repair, open repair, and conservative management of splenic artery aneurysms.
    Hogendoorn W; Lavida A; Hunink MG; Moll FL; Geroulakos G; Muhs BE; Sumpio BE
    J Vasc Surg; 2015 Jun; 61(6):1432-40. PubMed ID: 25827968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.
    Lynd LD; Goeree R; Crowther MA; O'Brien BJ
    Can J Clin Pharmacol; 2007; 14(2):e215-26. PubMed ID: 18000316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of core decompression.
    Soohoo NF; Vyas S; Manunga J; Sharifi H; Kominski G; Lieberman JR
    J Arthroplasty; 2006 Aug; 21(5):670-81. PubMed ID: 16877152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of the medical decision].
    Colin C; Delahaye F; Ecochard R; Landrivon G; Rabilloud M; Teboul F; Matillon Y
    Arch Mal Coeur Vaiss; 1993 Nov; 86(11):1597-603. PubMed ID: 8010859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder: a decision analytical approach.
    Lotan Y; Roehrborn CG
    J Urol; 2002 Jan; 167(1):75-9. PubMed ID: 11743279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.